Literature DB >> 12208953

An early regulatory function required in a cell type-dependent manner is expressed by the genomic but not the cDNA copy of the herpes simplex virus 1 gene encoding infected cell protein 0.

Alice P W Poon1, Saul J Silverstein, Bernard Roizman.   

Abstract

The alpha 0 genes of herpes simplex virus 1 (HSV-1) contain three exons. Earlier studies have shown that the substitution of genomic sequences with a cDNA copy does not alter the capacity of the virus to replicate or establish latent infection. Other studies have demonstrated that HSV-1 may express alternatively spliced forms of alpha 0 transcripts. The studies reported here centered on a mutant HSV-1(vCPc0) strain in which the genomic copies of the alpha 0 gene were replaced with cDNA copies. From our research, we report the following observations. (i) In contrast to events transpiring in cells infected with wild-type virus, the expression of HSV-1(vCPc0) genes was delayed or restricted to alpha genes for many hours in rabbit skin cells and to a lesser extent in HEp-2 cells but not in Vero cells. This delay in the expression of HSV-1(vCPc0) beta or gamma genes was also multiplicity of infection dependent. (ii) Exposure to MG132, a proteasomal inhibitor, before infection with wild-type virus had no significant effect on the accumulation of viral proteins in Vero cells and caused an only slight delay in viral gene expression in rabbit skin cells in a multiplicity of infection-dependent fashion. The drug had no effect when it was added to the medium 3 h after infection. (iii) Rabbit skin or HEp-2 cells exposed to MG132 3 h after infection with the HSV-1(vCPc0) mutant accumulated only alpha proteins. This restriction was cell type dependent but not multiplicity of infection dependent. (iv) Both the delay in the expression of beta and gamma genes and the effect of MG132 added to the medium 3 h after infection were rescued by restoration of the intron 1 sequences in the HSV-1(vCPc0) mutant. However, cells transduced by baculoviruses expressing intron 1 RNA did not complement the HSV-1(vCPc0) mutant, suggesting that the function of intron 1 is in cis rather than in trans. We came to the following conclusions as a result. (i) Post-alpha gene expression requires the involvement of the proteasomal pathway in a cell type-dependent manner. Consistent with this requirement, the proapoptotic functions of MG132 are blocked in cells infected before exposure to the drug but not after exposure. (ii) A function encoded by the alpha 0 gene that is absent from the cDNA copy is required for viral gene expression in a cell type- and multiplicity of infection-dependent fashion. The absence of this master function delays but does not ultimately block viral gene expression in the cell lines tested here.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208953      PMCID: PMC136486          DOI: 10.1128/jvi.76.19.9744-9755.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Glycoprotein D or J delivered in trans blocks apoptosis in SK-N-SH cells induced by a herpes simplex virus 1 mutant lacking intact genes expressing both glycoproteins.

Authors:  G Zhou; V Galvan; G Campadelli-Fiume; B Roizman
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  The U(S)3 protein kinase blocks apoptosis induced by the d120 mutant of herpes simplex virus 1 at a premitochondrial stage.

Authors:  J Munger; A V Chee; B Roizman
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity.

Authors:  C Van Sant; R Hagglund; P Lopez; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

4.  Herpes simplex virus 1-infected cell protein 0 contains two E3 ubiquitin ligase sites specific for different E2 ubiquitin-conjugating enzymes.

Authors:  Ryan Hagglund; Charles Van Sant; Pascal Lopez; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

5.  Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro.

Authors:  Chris Boutell; Seth Sadis; Roger D Everett
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Physical and functional interactions between herpes simplex virus immediate-early proteins ICP4 and ICP27.

Authors:  C A Panagiotidis; E K Lium; S J Silverstein
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

8.  Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.

Authors:  P M Ejercito; E D Kieff; B Roizman
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

9.  Induction and prevention of apoptosis in human HEp-2 cells by herpes simplex virus type 1.

Authors:  M Aubert; J O'Toole; J A Blaho
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

10.  Herpes simplex virus 1 alpha regulatory protein ICP0 functionally interacts with cellular transcription factor BMAL1.

Authors:  Y Kawaguchi; M Tanaka; A Yokoymama; G Matsuda; K Kato; H Kagawa; K Hirai; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

View more
  14 in total

1.  Analysis of herpes simplex virus ICP0 promoter function in sensory neurons during acute infection, establishment of latency, and reactivation in vivo.

Authors:  R L Thompson; May T Shieh; N M Sawtell
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 2.  Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1.

Authors:  Ryan Hagglund; Bernard Roizman
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

3.  Components of the REST/CoREST/histone deacetylase repressor complex are disrupted, modified, and translocated in HSV-1-infected cells.

Authors:  Haidong Gu; Yu Liang; Gail Mandel; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-16       Impact factor: 11.205

4.  ICP0 gene expression is a herpes simplex virus type 1 apoptotic trigger.

Authors:  Christine M Sanfilippo; John A Blaho
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  ICP0 and the US3 protein kinase of herpes simplex virus 1 independently block histone deacetylation to enable gene expression.

Authors:  Alice P W Poon; Haidong Gu; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

6.  U(S)3 and U(S)3.5 protein kinases of herpes simplex virus 1 differ with respect to their functions in blocking apoptosis and in virion maturation and egress.

Authors:  Alice P W Poon; Luca Benetti; Bernard Roizman
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  The co-chaperone BAG3 regulates Herpes Simplex Virus replication.

Authors:  Christos A Kyratsous; Saul J Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-16       Impact factor: 11.205

8.  The two functions of herpes simplex virus 1 ICP0, inhibition of silencing by the CoREST/REST/HDAC complex and degradation of PML, are executed in tandem.

Authors:  Haidong Gu; Bernard Roizman
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

9.  The cellular localization pattern of Varicella-Zoster virus ORF29p is influenced by proteasome-mediated degradation.

Authors:  Christina L Stallings; Gregory J Duigou; Anne A Gershon; Michael D Gershon; Saul J Silverstein
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

10.  The cellular protein daxx interacts with avian sarcoma virus integrase and viral DNA to repress viral transcription.

Authors:  James G Greger; Richard A Katz; Alexander M Ishov; Gerd G Maul; Anna Marie Skalka
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.